LINC00607 and diabetes mellitus: Together, our findings highlight LINC00607 as an emerging crucial epigenetic regulator in the vessel wall and the potential of targeting SE-derived lncRNAs such as LINC00607 for improved treatment or reversal of CVDs and metabolic memory in diabetes-associated vascular complications.